[1] 高蓓, 初海超, 芦文丽, 等. 1990-2019年中国恶性肿瘤疾病负担变化趋势分析[J]. 中华疾病控制杂志, 2022, 26(4):430-436, 489. [2] BENCHAOUIR R, RAMEAU P, DECRAENE C, et al. Evidence for a resident subset of cells with SP phenotype in the C2C12 myogenic line:a tool to explore muscle stem cell biology[J]. Exp Cell Res, 2004, 294(1):254-268. [3] 戴早. 基于多组学的前列腺癌细胞干性研究及复方中药CFF-1抑制前列腺癌的分子机制研究[D]. 南京:南京师范大学, 2021. [4] 张楠, 白素杭, 张富涵, 等. 肝癌干细胞分子标志物和干性维持机制研究进展[J]. 生物工程学报, 2021, 37(8):2719-2736. [5] 庞丽莹, 黄小龙, 朱玲玲, 等. 偶联CD133核酸适体的载紫杉醇PLGA-PEG纳米载体靶向清除CD133阳性肺癌干细胞[J]. 南方医科大学学报, 2022, 42(1):26-35. [6] 康毅, 周晏因, 朱蓉. EMT在结肠癌干细胞"干性"获得与维持中的作用及机制研究进展[J]. 海南医学, 2022, 33(6):782-786. [7] 张亚娜, 马望, 王峰, 等. ALDHs与胰腺癌以及胰腺癌干细胞的研究进展[J]. 肿瘤, 2016, 36(10):1176-1182. [8] ZHANG J F, ZHANG Y S, CHENG L, et al. Enrichment and characterization of cancer stem-like cells in ultra-low concentration of serum and non-adhesive culture system[J]. Am J Transl Res, 2018, 10(5):1552-1561. [9] CHEN S F, CHANG Y C, NIEH S, et al. Nonadhesive culture system as a model of rapid sphere formation with cancer stem cell properties[J]. PLoS One, 2012, 7(2):e31864. [10] WANG L, GUO H J, LIN C Y, et al. Enrichment and characterization of cancer stem-like cells from a cervical cancer cell line[J]. Mol Med Rep, 2014, 9(6):2117-2123. [11] GUPTA P B, FILLMORE C M, JIANG G, et al. Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells[J]. Cell, 2011, 146(4):633-644. [12] DIETER S M, BALL C R, HOFFMANN C M, et al. Distinct types of tumor-initiating cells form human colon cancer tumors and metastases[J]. Cell Stem Cell, 2011, 9(4):357-365. [13] LIU J, TAN Y H, ZHANG H F, et al. Soft fibrin gels promote selection and growth of tumorigenic cells[J]. Nat Mater, 2012, 11(8):734-741. [14] CHAICHAROENAUDOMRUNG N, KUNHORM P, NOISA P. Three-dimensional cell culture systems as an in vitro platform for cancer and stem cell modeling[J]. World J Stem Cells, 2019, 11(12):1065-1083. [15] ISHIGURO T, OHATA H, SATO A, et al. Tumor-derived spheroids:relevance to cancer stem cells and clinical applications[J]. Cancer Sci, 2017, 108(3):283-289. [16] MA R C, MANDELL J, LU F Q, et al. Do patient-derived spheroid culture models have relevance in chondrosarcoma research-[J]. Clin Orthop Relat Res, 2020, 479(3):477-490. [17] LEVENTAL K R, YU H, KASS L, et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling[J]. Cell, 2009, 139(5):891-906. [18] SAMUEL M S, LOPEZ J I, MCGHEE E J, et al. Actomyosin-mediated cellular tension drives increased tissue stiffness and β-catenin activation to induce epidermal hyperplasia and tumor growth[J]. Cancer Cell, 2011, 19(6):776-791. [19] ANTONI D, BURCKEL H, JOSSET E, et al. Three-dimensional cell culture:a breakthrough in vivo[J]. Int J Mol Sci, 2015, 16(3):5517-5527. [20] LOVITT C J, SHELPER T B, AVERY V M. Cancer drug discovery:recent innovative approaches to tumor modeling[J]. Expert Opin Drug Discov, 2016, 11(9):885-894. [21] HOARAU-VéCHOT J, RAFII A, TOUBOUL C, et al. Halfway between 2D and animal models:are 3D cultures the ideal tool to study cancer-microenvironment interactions-[J]. Int J Mol Sci, 2018, 19(1):181. [22] HABANJAR O, DIAB-ASSAF M, CALDEFIE-CHEZET F, et al. 3D cell culture systems:tumor application, advantages, and disadvantages[J]. Int J Mol Sci, 2021, 22(22):12200. [23] 钟菊嫦. 生物3D打印支架对细胞行为及功能的调控机制研究[D]. 长沙:湖南大学, 2018. [24] BAHCECIOGLU G, BASARA G, ELLIS B W, et al. Breast cancer models:engineering the tumor microenvironment[J]. Acta Biomater, 2020, 106:1-21. [25] 张弦, 蒋翠莲, 王宝偲, 等. 基于SP细胞分选法初步鉴定卵巢癌干细胞表面标志[J]. 东南大学学报:医学版, 2009, 28(6):491-496. [26] 尹婕, 潘凌亚, 温仪萍, 等. 人上皮性卵巢癌细胞系侧群细胞的肿瘤干细胞样细胞生物学特性及膜蛋白差异表达的鉴定[J]. 基础医学与临床, 2022, 42(2):221-227. [27] 刘贵远, 周海华, 张超逸, 等. 人结肠直肠癌组织中侧群细胞分选、鉴定及其化疗耐药特性的初步研究[J]. 实用临床医药杂志, 2020, 24(4):31-35. [28] 耿嘉, 刘越敏, 罗慧英. 在胃癌BGC-823细胞中侧群细胞的分选及其干细胞特性研究[J]. 中国临床药理学杂志, 2019, 35(9):873-876. [29] 王锡山, 刘彦龙, 杨艳梅. 大肠癌细胞系Lovo中亚群(SP)细胞的分离培养和鉴定[J]. 世界华人消化杂志, 2007, 15(9):953-959. [30] 朱素丽, 陈运昊, 姚尖平, 等. 肉桂醛调控CD44s/STAT3信号通路抑制胰腺癌细胞增殖和肿瘤细胞干性[J]. 中国药理学通报, 2022, 38(5):676-683. [31] 成睿珍, 张春艳, 刘凤婷, 等. 灵芝烯酸B诱导Oct4去SUMO化激活G0期胃癌侧群细胞[J]. 天津中医药, 2019, 36(4):396-399. [32] 谢正元, 赖月亮, 刘思甫, 等. 槐耳颗粒逆转肝癌侧群细胞耐阿霉素的实验研究[J]. 南昌大学学报:医学版, 2020, 60(5):13-16, 21. [33] WU A H, OH S, WIESNER S M, et al. Persistence of CD133+ cells in human and mouse glioma cell lines:detailed characterization of GL261 glioma cells with cancer stem cell-like properties[J]. Stem Cells Dev, 2008, 17(1):173-184. [34] 谢宇杰, 龚小林. 流式细胞术在肿瘤干细胞中的应用进展[J]. 海南医学, 2019, 30(8):1062-1065. [35] MA L, LAI D M, LIU T, et al. Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3[J]. Acta Biochim Biophys Sin:Shanghai, 2010, 42(9):593-602. [36] 郑露露, 蔡永萍, 胡勇, 等. FoxM1通过促进肿瘤干细胞化参与骨肉瘤细胞对顺铂的耐药[J]. 临床与实验病理学杂志, 2020, 36(4):411-416. [37] HUSS W J, GRAY D R, GREENBERG N M, et al. Breast cancer resistance protein-mediated efflux of androgen in putative benign and malignant prostate stem cells[J]. Cancer Res, 2005, 65(15):6640-6650. [38] YANG L Q, SHI P F, ZHAO G C, et al. Targeting cancer stem cell pathways for cancer therapy[J]. Signal Transduct Target Ther, 2020, 5:8. [39] 宿晨, 陈钰, 陈道桢. 三阴性乳腺癌肿瘤干细胞的悬浮培养及干样细胞表面标志物的研究进展[C]//2021年中国肿瘤标志物学术大会暨第十五届肿瘤标志物青年科学家论坛论文集. 线上会议, 2021:439-440. [40] 李民举. 肝癌干细胞表面标志物研究进展综述[J]. 现代商贸工业, 2019, 40(13):75-76. [41] ELKASHTY O A, ABU ELGHANAM G, SU X Y, et al. Cancer stem cells enrichment with surface markers CD271 and CD44 in human head and neck squamous cell carcinomas[J]. Carcinogenesis, 2019, 41(4):458-466. [42] 张继雯, 宋殿荣. 人类子宫内膜肿瘤干细胞的研究进展[J]. 国际妇产科学杂志, 2013, 40(4):327-330. [43] 王静, 孔源, 邓福生. 成球培养法富集胰腺癌肿瘤干细胞的研究[J]. 安徽医学, 2019, 40(12):1303-1305. [44] LIU L, BORLAK J. Advances in liver cancer stem cell isolation and their characterization[J]. Stem Cell Rev Rep, 2021, 17(4):1215-1238. |